Presentation TCT 2021 TCT 612: Unprotected Left Main Disease and TAVR: What Do We Do First? Presenter: Ronald Rivas Gálvez November 05, 2021
Presentation TCT 2021 Clinically Significant Phenomenon With Consequences Presenter: Raj Makkar November 05, 2021
Presentation TCT 2021 AorticLab GEMINI - Functional Recovery of Stenotic Aortic Valve With A Double Ultrasound Wave Effect Presenter: Federico De Marco November 05, 2021
Presentation TCT 2021 Longer-term Concerns: What Comes Next? Presenter: Tsuyoshi Kaneko November 05, 2021
Presentation TCT 2021 First Dedicated Transcatheter Leaflet Splitting Device From Bench to FIH (ShortCut) Presenter: Susheel Kodali November 05, 2021
Presentation TCT 2021 Short-term Priorities: Optimal Intervention for the Patient With Longer Life Expectancy Presenter: Amar Krishnaswamy November 05, 2021
Presentation TCT 2021 DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics Presenter: Samir Kapadia November 05, 2021
Presentation TCT 2021 A Pressure Wire for Valve Implantation and Continuous Hemodynamic Monitoring During TAVR Procedures: Initial Experience with the SavvyWire Presenter: Josep Rodés-Cabau November 05, 2021
Presentation TCT 2021 Evaluation of the OpSens OptoWire III and its Novel TAVR Algorithm to Measure Pressure Gradient before and After TAVR Compared With Hemodynamic Value Derived by Catheterization and Echocardiogram Presenter: Philippe Genereux November 05, 2021
Presentation TCT 2021 The Journey in Clinical Context (Case Presentation) Presenter: Itsik Ben-Dor November 05, 2021
Presentation TCT 2021 Innovation in the TAVR Space: Remaining Challenges and Opportunities Presenter: Eberhard Grube November 05, 2021
News Conference News TCT 2021 More Complications With Plug Closure After TAVI: CHOICE-CLOSURE Michael O'Riordan November 05, 2021
News Conference News TCT 2021 TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021
Presentation TCT 2021 PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk Presenter: David Cohen November 05, 2021
News Conference News TCT 2021 SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years Todd Neale November 05, 2021
Presentation TCT 2021 SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk Presenter: Nicolas Van Mieghem November 05, 2021
Presentation TCT 2021 TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial Presenter: Tobias Schmidt November 05, 2021
Presentation TCT 2021 TCT 540: LAVA-ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve-in-Valve TAVR and PCI Presenter: Michael Chiang November 04, 2021
Presentation TCT 2021 TCT 535: Device Embolization of TAVR Valve In Ascending Aorta Requiring Surgical Aortic Valve Replacement Presenter: Yash Jobanputra November 04, 2021
Presentation TCT 2021 Cerebral Protection in TAVR: The PROTEMBO C Trial Presenter: Tobias Schmidt November 04, 2021